Anirban Sen Gupta
Research InterestsBiomaterials, Nanomedicine, Hemostasis Thrombosis and Inflammatory Diseases
Teaching InterestsBiomaterials, Nanomedicine, Hemostasis Thrombosis and Inflammatory Diseases
News About Anirban Sen Gupta
National Academy of Inventors names seven Case Western Reserve University researchers to 2024 class of senior members
The National Academy of Inventors (NAI) has named seven Case Western Reserve University researchers to its 2024 class of senior members, an honor that recognizes their “remarkable innovation-producing technologies that have brought, or aspire to bring, real impact on the welfare of society.” This year’s class of NAI senior members is the largest to date and hails from 60 NAI-member institutions nationally. The Daily sat down to learn more about the seven honorees from CWRU.
Receiving the highest honor among the global biomaterials community, Anirban Sen Gupta is now one of less than 500 individuals to become a Fellow of Biomaterials Science and Engineering (FBSE).
Even as biomedical engineer Anirban Sen Gupta refines artificial platelets to stem traumatic bleeding, he and his colleagues are seeking new uses for their synthetic solution. The latest application to show promise involves providing synthetic platelets to treat a genetic condition that prevents blood from clotting, Von Willebrand disease (VWD). The most common of all bleeding disorders, VWD is found in up to 1% of the U.S. population (roughly 3 million people), according to the Centers for Disease Control and Prevention.
University of Maryland leads team of multiple universities and biotech companies; CWRU to evaluate and optimize synthetic blood products
Case Western Reserve University bioengineer awarded $2.5 million from U.S. Army to boost nanotechnology for treating wounded soldiers and patients with bleeding defects
Anirban Sen Gupta In the News
Anirban Sen Gupta, the Leonard Case Jr. Professor of Engineering at Case School of Engineering, discussed his new research that seeks components that mimic the functions of real blood into something that can be freeze-dried and easily stored as powder then reconstituted on demand using saline. “That’s why this is so exciting—this could be the culmination of a century of efforts by human beings to create a substitute for whole blood,” he said.
Anirban Sen Gupta, the Leonard Case Jr. Professor of Engineering at Case School of Engineering, discussed efforts to develop groundbreaking research to save people’s lives who need blood during critical circumstances. “What we have been trying to do, for a long time, and we are continuing to do is to create a synthetic materials-based systems,” he said.
Anirban Sen Gupta, professor of biomedical engineering, discussed his new technology “SanguiStop,” which allows a clot-promoting enzyme called thrombin to be intravenously delivered in a targeted manner to a bleeding area—especially to the site of internal injuries.